Abnormal Pap tests after the HPV vaccine

Australian Family Physician

Volumn 38, Issue 12, 2009, Pages 977-979

  Heley, Stella ^a   Brotherton, Julia ^a,b  

^a VICTORIAN CYTOLOGY SERVICE   (Australia)

^b National HPV Vaccination Program Register   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CHILD; FEMALE; HUMAN; IMMUNOLOGY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; TIME; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VACCINATION; VAGINA SMEAR; VIROLOGY;

ADOLESCENT; ADULT; AUSTRALIA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHILD; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; VACCINATION; VAGINAL SMEARS; YOUNG ADULT;

EID: 77953281529     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Schiffman M, Castle PE, Jeronima J, Rodruguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
2. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, et al,. on behalf of the WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens - Part B: biological agents. Lancet Oncol 2009;10:321-22.
3. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries.. Cancer in Australia: An overview, 2008. Cancer series no. 46. Cat. no. CAN 42. Canberra: AIHW, 2008.
4. National Health and Medical Research Council (NHMRC).. Screening to prevent cervical cancer: Guidelines for the management of asymptomatic women with screen detected abnormalities. Canberra: NHMRC, 2005.
5. Australian Institute of Health and Welfare.. Cervical screening in Australia 2005- 2006. Cancer series no 41 cat no CAN 36 AIHW. Canberra: AIHW, 2008.
6. McCredie MR, Sharples KJ, Paul C, et al.. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: A retrospective cohort study. Lancet Oncol 2008;9:425-34.
7. Brotherton JML, Deeks SL, Campbell-Lloyd S, et al.. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell 2008;32:457-61.
8. Weisberg E, Bateson D, McCaffery K, Skinner SR.. HPV vaccination catch up program - utilisation by young Australian women. Aust Fam Physician 2009;38:72-6.
9. Ault KA.. FUTURE II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomised clinical trials. Lancet 2007;369:1861-8.
10. Harper DM, Franco EL, Wheeler CM, et al.. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomized control trial. Lancet 2006;367:1247-55.
11. Smith JS, Lindsay L, Hoots B, et al.. Human papillomavirus type distribution in invasive cervical cancer and high grade cervical lesions: A meta-analysis update. Int J Cancer 2007;121:621-32.
12. Brotherton JML.. How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Vaccine 2008;26:250-6.
13. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM.. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1157-64.
14. Garland SM, Steben M, Sings HL, et al.. Natural history of genital warts: Analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. J Infect Dis 2009;199:805-14.
15. Kjaer SK, Breugelmans G, Munk C, et al.. Population-based prevalence, type - and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008;123:1864-70.
16. Cuschieri KS, Cubie HA, Whitley MW, et al.. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Path 2004;57:68-72.
17. Winer RL, Steben M, Sings HL, et al.. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008;197:279-82.
18. Winer RL, Lee SK, Hughes JP, et al.. Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218-26.
19. Woodman CB, Collins S, Winter H, et al.. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 2001;357:1831-6.
20. Brown DR, Shew ML, Qadadri B, et al.. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005;191:182-92.
21. Rissel CE, Richters J, Grulich AE, de Visser RO, Smith AM.. Sex in Australia: Selected characteristics of regular sexual relationships. Aust N Z J Public Health 2003;27:124-30.